Heart 1998;80:45-48 ( July )
Adrenergic blockers lower renin in patients treated with ACE
inhibitors and diuretics
a Klinik
und Poliklinik für Innere Medizin II, University of Regensburg, D
93042 Regensburg, Germany, b Institut für
Epidemiologie und Sozialmedizin, Universität Münster, Münster, and
GSF München, Germany, c Departments of Pharmacology and Internal
Medicine, Erasmus University, Rotterdam, Netherlands
Correspondence to: Dr Holmer.
Accepted for publication 22 January 1998
Objective
To examine
the effect of concomitant intake of
blockers with angiotensin
converting enzyme (ACE) inhibitors, diuretics, or both on plasma renin
concentrations in a population based sample (MONICA survey, Augsburg, Germany).
Subject and
methods
728 individuals were studied, of whom 171 were treated using monotherapy (ACE inhibitor (n = 21), diuretic
(n = 10), or
blocker (n = 72)), or combination treatment (ACE
inhibitor + diuretic (n = 32), ACE inhibitor +
blocker (n = 7),
diuretic +
blocker (n = 22), ACE inhibitor + diuretic +
blocker (n = 7)). The remaining 557 individuals were untreated.
Indications for treatment were hypertension (75%), coronary artery
disease with (12%) or without (3%) hypertension, or unknown (10%).
Results
Mean (SEM)
renin concentrations in individuals treated with an ACE inhibitor (41 (8) mU/l), a diuretic (41 (10) mU/l), or the combination of an ACE
inhibitor and a diuretic (54 (10) mU/l) were raised compared with
untreated individuals (17 (1) mU/l; p < 0.05 each). Monotherapy
with a
blocker, however, decreased mean renin concentrations (12 (1) mU/l; p < 0.01 v untreated). Renin
concentrations in individuals taking a
blocker with either an ACE
inhibitor (21 (8) mU/l), or a diuretic (22 (4) mU/l), or with both an
ACE inhibitor and a diuretic (21 (7) mU/L), were significantly lower
compared with renin concentrations in groups not receiving
blocker
treatment (p < 0.05 each).
Conclusion
These data
suggest that the upregulation of renin by treatment with ACE
inhibitors, diuretics, or both can be largely prevented by concomitant
blocker treatment.
receptor blocker;
angiotensin
converting enzyme inhibitor;
renin;
hypertension
© 1998 by Heart
This article has been cited by other articles:
-
Montalescot, G., Collet, J.-P.
(2005). Preserving cardiac function in the hypertensive patient: why renal parameters hold the key. Eur Heart J
26: 2616-2622
[Abstract] [Full Text] -
Solal, A. C., Jondeau, G., Beauvais, F., Berdeaux, A.
(2004). Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure. Eur J Heart Fail
6: 463-466
[Abstract] [Full Text] -
Weinberg, M. S, Weinberg, A. J, Zappe, D. H
(2000). Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. Journal of Renin-Angiotensin-Aldosterone System
1: 217-233
-
Schunkert, H.
(2000). The importance of early intervention in CHF -- signs and symptom relief. Journal of Renin-Angiotensin-Aldosterone System
1: 17-23
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
